Literature DB >> 21598804

The structural effect of the E148Q MEFV mutation on the pyrin protein: a study using a quantum chemistry model.

Alexey Naimushin1, Mirav Lidar, Ilan Ben Zvi, Avi Livneh.   

Abstract

BACKGROUND: Familial Mediterranean fever (FMF) is a recessively inherited disease with a variety of clinical presentations. The disease is associated with mutations in the FMF gene (MEFV), which encodes for the pyrin protein. The role of the E148Q pyrin mutation in the FMF phenotype remains inconclusive, and some authors even view it as a disease-insignificant polymorphism. The calculated change imposed by this mutation on pyrin structure may help to understand the role of this mutation.
OBJECTIVES: To calculate the relative electrochemical effect of the E148Q mutation on the structure of pyrin protein.
METHODS: The electronic properties of the wild-type pyrin molecule and its common mutated forms were computed for the full-length molecule and its segments, encoded by exons 2 and 10, using the HyperChem 7.5 program with one of the molecular mechanical methods (MM+). The change in the structure of the molecule, expressed as a change in energy gain, conferred by the mutations was determined.
RESULTS: The E148Q mutation caused deviation from the wildtype pyrin segment encoded by exon 2 by 1.15% and from the whole pyrin molecule by 0.75%, which was comparable to the R202Q mutation and less than the M694V mutation which caused a deviation from the wild-type structure of the whole pyrin molecule by 1.5%.
CONCLUSIONS: A quantum chemistry-based model suggests that the structural effect of the E148Q mutation is indeed low but not zero.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598804

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report.

Authors:  Eray Eroglu; Ismail Kocyigit; Ozturk Ates; Aydin Unal; Murat Hayri Sipahioglu; Hulya Akgun; Bulent Tokgoz; Oktay Oymak
Journal:  Int Urol Nephrol       Date:  2012-01-20       Impact factor: 2.370

2.  CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.

Authors:  Junichi Watanabe; Ken Sato; Yukiko Osawa; Toshikatsu Horiuchi; Shoichiro Kato; Reina Hikota-Saga; Takaaki Maekawa; Takeshi Yamamura; Ayako Kobayashi; Shinichi Kobayashi; Fumihiko Kimura
Journal:  Int J Hematol       Date:  2018-03-29       Impact factor: 2.490

3.  Familial Mediterranean fever is no longer a rare disease in Japan.

Authors:  Kiyoshi Migita; Yasumori Izumi; Yuka Jiuchi; Nozomi Iwanaga; Chieko Kawahara; Kazunaga Agematsu; Akihiro Yachie; Junya Masumoto; Keita Fujikawa; Satoshi Yamasaki; Tadashi Nakamura; Yoshifumi Ubara; Tomohiro Koga; Yoshikazu Nakashima; Toshimasa Shimizu; Masataka Umeda; Fumiaki Nonaka; Michio Yasunami; Katsumi Eguchi; Koh-Ichiro Yoshiura; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2016-07-30       Impact factor: 5.156

4.  Familial Mediterranean fever presenting as fever of unknown origin in Korea.

Authors:  Jun Hee Lee; Jong Hyun Kim; Jung Ok Shim; Kwang Chul Lee; Joo Won Lee; Jung Hwa Lee; Jae Jin Chae
Journal:  Korean J Pediatr       Date:  2016-11-30

5.  Intestinal malrotation as a misdiagnosis of pediatric colchicine resistant familial Mediterranean fever.

Authors:  Merav Heshin-Bekenstein; Philip J Hashkes
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-10       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.